Skip to main content

Table 10 Changes in Osame motor disability score (OMDS) in patients with HAM/TSP who had been observed for four years (n = 148)

From: Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan

  Baselinea 2nd-year pointa 3rd-year pointa 4th-year pointa 5th-year pointa ∆OMDS per four yearsb p value c
All patients 5.80 ± 2.19 5.99 ± 2.31 6.21 ± 2.36 6.28 ± 2.34 6.37 ± 2.31 0.57
(0.42–0.73)
< 0.001
Steroid group 5.96 ± 2.27 6.15 ± 2.35 6.40 ± 2.48 6.47 ± 2.51 6.60 ± 2.49 0.64
(0.30–0.98)
< 0.001
Steroid-history group 6.56 ± 2.42 6.81 ± 2.64 7.08 ± 2.61 7.14 ± 2.54 7.22 ± 2.50 0.67
(0.32–1.01)
< 0.001
Untreated group 4.84 ± 1.44 5.00 ± 1.63 5.19 ± 1.75 5.22 ± 1.81 5.25 ± 1.70 0.41
(0.13–0.68)
0.005
Miscellaneous group 5.67 ± 2.13 5.85 ± 2.14 5.97 ± 2.08 6.09 ± 1.94 6.21 ± 1.93 0.55
(0.23–0.87)
0.002
  1. aData are expressed as mean ± standard deviation
  2. bData are expressed as point estimates and 95% confidence intervals
  3. cStatistical methods used the paired t-test (baseline vs. 5th-year point)